TSS
SMMT icon

Two Sigma Securities’s Summit Therapeutics SMMT Stock Holding History

Two Sigma Securities’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$182K Buy
+12,491
New +$222K 0.02% 1198
2025
Q3 		– Sell
-13,149
Closed -$280K – 1949
2025
Q2 		$280K Buy
+13,149
New +$300K 0.03% 698
2022
Q4 		– Sell
-17,092
Closed -$20K – 3203
2022
Q3 		$20K Buy
+17,092
New +$19.3K ﹤0.01% 2298
2022
Q1 		– Sell
-19,474
Closed -$52K – 2472
2021
Q4 		$52K Buy
+19,474
New +$93.6K ﹤0.01% 1271

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Two Sigma Securities's SMMT Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Summit Therapeutics (SMMT) in Q2 2026: 12,491 shares worth $182K. The stake represents 0.02% of the portfolio and ranks #1198 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in SMMT as recently as Q2 2025.

Two Sigma Securities first reported a position in SMMT in Q4 2021 and has held it in 4 quarters since. The position peaked at $280K in Q2 2025. 243 funds tracked by Wall St. Rank hold SMMT as of Q2 2026.

  • Two Sigma Securities held 12,491 shares of Summit Therapeutics worth $182K as of Q2 2026.
  • Summit Therapeutics was a new Two Sigma Securities position in Q2 2026.
  • Summit Therapeutics made up 0.02% of Two Sigma Securities's portfolio in Q2 2026, its #1198 holding.
  • Two Sigma Securities first reported a position in Summit Therapeutics in Q4 2021 and has held it in 4 quarters since.
  • Two Sigma Securities's Summit Therapeutics position peaked at $280K in Q2 2025.
  • 243 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.